Labcorp (LH)
(Delayed Data from NYSE)
$209.54 USD
+0.33 (0.16%)
Updated Mar 18, 2024 04:00 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for Labcorp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 537 | 430 | 1,473 | 1,321 | 338 |
Receivables | 2,099 | 3,017 | 2,978 | 3,017 | 2,025 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 475 | 471 | 401 | 423 | 245 |
Other Current Assets | 655 | 707 | 478 | 365 | 374 |
Total Current Assets | 3,765 | 4,625 | 5,331 | 5,125 | 2,981 |
Net Property & Equipment | 2,912 | 2,956 | 2,815 | 2,730 | 2,637 |
Investments & Advances | 27 | 66 | 61 | 74 | 85 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 8 | 22 | 21 | 9 |
Intangibles | 9,485 | 12,068 | 11,694 | 11,713 | 11,900 |
Deposits & Other Assets | 537 | 433 | 463 | 410 | 435 |
Total Assets | 16,725 | 20,155 | 20,385 | 20,072 | 18,046 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 1,000 | 301 | 2 | 377 | 415 |
Accounts Payable | 828 | 935 | 621 | 639 | 632 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 6 | 6 | 11 | 7 | 8 |
Accrued Expenses | 804 | 1,069 | 1,404 | 1,358 | 942 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 422 | 582 | 559 | 507 | 451 |
Total Current Liabilities | 3,225 | 3,079 | 2,783 | 3,079 | 2,656 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 418 | 736 | 763 | 905 | 943 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 4,055 | 5,039 | 5,417 | 5,419 | 5,790 |
Non-Current Capital Leases | 79 | 84 | 85 | 84 | 91 |
Other Non-Current Liabilities | 409 | 423 | 402 | 526 | 383 |
Minority Interest (Liabilities) | 16 | 19 | 21 | 21 | 20 |
Total Liabilities | 8,850 | 10,059 | 10,112 | 10,712 | 10,479 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 8 | 8 | 9 | 9 | 9 |
Capital Surplus | 38 | 0 | 0 | 110 | 27 |
Retained Earnings | 7,888 | 10,582 | 10,457 | 9,402 | 7,904 |
Other Equity | -59 | -493 | -192 | -162 | -372 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 7,875 | 10,097 | 10,273 | 9,360 | 7,567 |
Total Liabilities & Shareholder's Equity | 16,725 | 20,155 | 20,385 | 20,072 | 18,046 |
Total Common Equity | 7,875 | 10,097 | 10,273 | 9,360 | 7,567 |
Shares Outstanding | 84.90 | 88.60 | 95.70 | 97.40 | 97.10 |
Book Value Per Share | 92.76 | 113.96 | 107.35 | 96.10 | 77.93 |
Fiscal Year End for Labcorp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 537 | 728 | 1,931 | 394 | 430 |
Receivables | 2,099 | 2,065 | 2,043 | 3,050 | 3,017 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 475 | 461 | 488 | 481 | 471 |
Other Current Assets | 655 | 700 | 660 | 770 | 707 |
Total Current Assets | 3,765 | 3,954 | 5,121 | 4,695 | 4,625 |
Net Property & Equipment | 2,912 | 2,821 | 2,762 | 2,944 | 2,956 |
Investments & Advances | 27 | 40 | 67 | 66 | 66 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 8 | 6 | 8 | 8 |
Intangibles | 9,485 | 9,608 | 9,336 | 12,028 | 12,068 |
Deposits & Other Assets | 537 | 457 | 426 | 459 | 433 |
Total Assets | 16,725 | 16,886 | 17,719 | 20,200 | 20,155 |
Liabilities & Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Notes Payable | 1,000 | 991 | 301 | 301 | 301 |
Accounts Payable | 828 | 691 | 713 | 881 | 935 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 6 | 6 | 7 | 6 | 6 |
Accrued Expenses | 804 | 690 | 658 | 930 | 1,069 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 422 | 361 | 350 | 587 | 582 |
Total Current Liabilities | 3,225 | 2,901 | 2,183 | 2,886 | 3,079 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 418 | 500 | 565 | 737 | 736 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 4,055 | 4,428 | 5,042 | 5,052 | 5,039 |
Non-Current Capital Leases | 79 | 80 | 82 | 82 | 84 |
Other Non-Current Liabilities | 409 | 419 | 414 | 423 | |
Minority Interest (Liabilities) | 16 | 19 | 20 | 19 | 19 |
Total Liabilities | 8,850 | 9,013 | 8,934 | 9,859 | 10,059 |
Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 8 | 8 | 8 | 8 | 8 |
Capital Surplus | 38 | 5 | 94 | 48 | 0 |
Retained Earnings | 7,888 | 8,070 | 8,836 | 10,730 | 10,582 |
Other Equity | -59 | -209 | -154 | -444 | -493 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 7,875 | 7,873 | 8,785 | 10,342 | 10,097 |
Total Liabilities & Shareholder's Equity | 16,725 | 16,886 | 17,719 | 20,200 | 20,155 |
Total Common Equity | 7,875 | 7,873 | 8,785 | 10,342 | 10,097 |
Shares Outstanding | 84.90 | 84.90 | 88.60 | 88.50 | 88.60 |
Book Value Per Share | 92.76 | 92.73 | 99.15 | 116.85 | 113.96 |